Obalon_Logo_Teal_2c.jpg
Obalon Announces Third Quarter 2020 Financial Results
November 06, 2020 16:45 ET | Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment
May 11, 2020 08:30 ET | Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and...
Obalon_Logo_Teal_2c.jpg
William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director
May 08, 2020 08:00 ET | Obalon Therapeutics, Inc.
SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
Obalon_Logo_Teal_2c.jpg
Obalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death, With Liquid-Filled Intragastric Balloons
April 28, 2020 09:00 ET | Obalon Therapeutics, Inc.
SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Engages Canaccord Genuity to Explore Financial and Strategic Alternatives
March 25, 2020 08:30 ET | Obalon Therapeutics, Inc.
SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
Obalon_Logo_Teal_2c.jpg
Obalon Temporarily Suspends New Patient Sales at Its Retail Treatment Centers Due to Coronavirus Pandemic
March 17, 2020 17:21 ET | Obalon Therapeutics, Inc.
SAN DIEGO, Calif., March 17, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Fourth Quarter and Full Year 2019 Financial Results
February 27, 2020 07:31 ET | Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Opening of Second Retail Treatment Center in Orange County, CA
February 20, 2020 08:15 ET | Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
Obalon_Logo_Teal_2c.jpg
Obalon Schedules Fourth Quarter and Year-End 2019 Financial Results Conference Call for February 27, 2020 at 8:30 a.m. Eastern Time
February 13, 2020 09:00 ET | Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon_Logo_Teal_2c.jpg
Obalon Enters into New Stock Purchase Agreement with Lincoln Park Capital Fund
February 07, 2020 16:15 ET | Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...